Midwest Professional Planners Ltd (MPPL)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.37M | Buy |
29,579
+588
| +2% | +$48.5K | 0.56% | 61 |
|
|
2025
Q4 | $2.47M | Sell |
28,991
-7,779
| -21% | -$638K | 0.59% | 57 |
|
|
2025
Q3 | $2.86M | Sell |
36,770
-681
| -2% | -$53.2K | 0.7% | 52 |
|
|
2025
Q2 | $2.93M | Buy |
37,451
+413
| +1% | +$30.8K | 0.77% | 45 |
|
|
2025
Q1 | $2.68M | Buy |
37,038
+254
| +0.7% | +$18.2K | 0.84% | 40 |
|
|
2024
Q4 | $2.72M | Buy |
36,784
+2,343
| +7% | +$164K | 0.81% | 35 |
|
|
2024
Q3 | $2.27M | Buy |
34,441
+2,551
| +8% | +$185K | 0.69% | 45 |
|
|
2024
Q2 | $2.95M | Buy |
31,890
+260
| +0.8% | +$23K | 0.98% | 24 |
|
|
2024
Q1 | $3.02M | Buy |
+31,630
| New | +$2.66M | 1.06% | 24 |
|
|
2023
Q4 | – | Sell |
-30,898
| Closed | -$2.14M | – | 131 |
|
|
2023
Q3 | $2.14M | Buy |
30,898
+1,763
| +6% | +$142K | 0.96% | 31 |
|
|
2023
Q2 | $2.75M | Buy |
29,135
+2,338
| +9% | +$203K | 1.2% | 23 |
|
|
2023
Q1 | $2.22M | Buy |
26,797
+932
| +4% | +$73.3K | 1.08% | 22 |
|
|
2022
Q4 | $1.93M | Buy |
25,865
+1,513
| +6% | +$117K | 1.07% | 30 |
|
|
2022
Q3 | $2.01M | Buy |
24,352
+1,098
| +5% | +$106K | 1.2% | 16 |
|
|
2022
Q2 | $2.21M | Buy |
23,254
+818
| +4% | +$84.7K | 1.25% | 18 |
|
|
2022
Q1 | $2.64M | Buy |
22,436
+873
| +4% | +$97.9K | 1.3% | 17 |
|
|
2021
Q4 | $2.79M | Buy |
21,563
+105
| +0.5% | +$12.2K | 1.36% | 17 |
|
|
2021
Q3 | $2.43M | Sell |
21,458
-125
| -0.6% | -$14.3K | 1.29% | 17 |
|
|
2021
Q2 | $2.23M | Buy |
21,583
+15,039
| +230% | +$1.42M | 1.16% | 21 |
|
|
2021
Q1 | $1.23M | Sell |
6,544
-14,970
| -70% | -$1.27M | 1.22% | 19 |
|
|
2020
Q4 | $1.96M | Buy |
21,514
+229
| +1% | +$19K | 1.21% | 18 |
|
|
2020
Q3 | $1.7M | Buy |
21,285
+1,027
| +5% | +$80.1K | 1.2% | 21 |
|
|
2020
Q2 | $1.4M | Buy |
20,258
+626
| +3% | +$44.5K | 1.1% | 22 |
|
|
2020
Q1 | $1.23M | Buy |
19,632
+462
| +2% | +$33.3K | 1.22% | 20 |
|
|
2019
Q4 | $1.49M | Sell |
19,170
-459
| -2% | -$35.8K | 1.22% | 23 |
|
|
2019
Q3 | $1.44M | Buy |
19,629
+66
| +0.3% | +$4.64K | 1.29% | 18 |
|
|
2019
Q2 | $1.21M | Sell |
19,563
-6,123
| -24% | -$370K | 1.12% | 23 |
|
|
2019
Q1 | $1.64M | Sell |
25,686
-2,211
| -8% | -$126K | 1.58% | 17 |
|
|
2018
Q4 | $1.42M | Sell |
27,897
-651
| -2% | -$32.9K | 1.53% | 16 |
|
|
2018
Q3 | $1.66M | Buy |
28,548
+465
| +2% | +$22.7K | 1.52% | 16 |
|
|
2018
Q2 | $1.36M | Sell |
28,083
-336
| -1% | -$15.7K | 1.22% | 15 |
|
|
2018
Q1 | $1.32M | Buy |
28,419
+405
| +1% | +$17.6K | 1.19% | 18 |
|
|
2017
Q4 | $1.05M | Buy |
+28,014
| New | +$1.03M | 0.96% | 19 |
|
Other funds holding EW
VCM
VPM
Midwest Professional Planners Ltd (MPPL)'s EW Position: Q1 2026 in Review
Midwest Professional Planners Ltd (MPPL) increased its Edwards Lifesciences (EW) stake by 2% in Q1 2026, buying an estimated $48.5K and bringing the position to 29,579 shares worth $2.37M. The position accounts for 0.56% of the portfolio, ranked #61.
Midwest Professional Planners Ltd (MPPL) first reported a position in EW in Q4 2017 and has held it in 33 quarters since. The position peaked at $3.02M in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Midwest Professional Planners Ltd (MPPL) held 29,579 shares of Edwards Lifesciences worth $2.37M as of Q1 2026.
- Midwest Professional Planners Ltd (MPPL) bought 588 Edwards Lifesciences shares in Q1 2026, an estimated $48.5K.
- Edwards Lifesciences made up 0.56% of Midwest Professional Planners Ltd (MPPL)'s portfolio in Q1 2026, its #61 holding.
- Midwest Professional Planners Ltd (MPPL) first reported a position in Edwards Lifesciences in Q4 2017 and has held it in 33 quarters since.
- Midwest Professional Planners Ltd (MPPL)'s Edwards Lifesciences position peaked at $3.02M in Q1 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q1 2026, filed 5 May 2026.